CCL President Robert S. Peck spoke at the opening of the South Carolina Association for Justice’s annual Auto Torts Seminar Dec. 5 in Atlanta, describing the efforts that CCL has made in fighting damage caps in the courts, making sense of the U.S. Supreme Court’s jurisprudence on preemption to permit plaintiffs to bring their cases, and dealing with a variety of other obstacles to access to justice. The well-attended seminar, often called "the best seminar in the region, if not the country," by trial lawyers from across the South, provided CCL with an opportunity to showcase its most recent victories in the courts, as well as some of the issues currently on its docket.  In the course of his remarks, Peck talked about CCL’s wins in the Florida Supreme Court in Estate of McCall v. United States, which struck down the state’s aggregate damage cap in medical malpractice cases, as well as Fulgenzi v. PLIVA in the Sixth Circuit and In re: Reglan Litigation in the Appellate Division of the New Jersey Superior Court, both of which held that failure-to-warn claims against generic drug manufacturers were not preempted by federal law when the manufacturer has failed to update its label to encompass the warnings appearing on the name-brand version of the drug.